313 related articles for article (PubMed ID: 18288891)
1. Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance.
Tanabe K; Liu Z; Patel S; Doble BW; Li L; Cras-Méneur C; Martinez SC; Welling CM; White MF; Bernal-Mizrachi E; Woodgett JR; Permutt MA
PLoS Biol; 2008 Feb; 6(2):e37. PubMed ID: 18288891
[TBL] [Abstract][Full Text] [Related]
2. Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice.
Liu Y; Tanabe K; Baronnier D; Patel S; Woodgett J; Cras-Méneur C; Permutt MA
Diabetologia; 2010 Dec; 53(12):2600-10. PubMed ID: 20821187
[TBL] [Abstract][Full Text] [Related]
3. Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.
Song R; Wang X; Mao Y; Li H; Li Z; Xu W; Wang R; Guo T; Jin L; Zhang X; Zhang Y; Zhou N; Hu R; Jia J; Lei Z; Irwin DM; Niu G; Tan H
Gene; 2013 Oct; 529(1):50-6. PubMed ID: 23860320
[TBL] [Abstract][Full Text] [Related]
4. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of GSK-3β restores delayed gastric emptying in obesity-induced diabetic female mice.
Sampath C; Srinivasan S; Freeman ML; Gangula PR
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G481-G493. PubMed ID: 32812777
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.
Patel S; Doble BW; MacAulay K; Sinclair EM; Drucker DJ; Woodgett JR
Mol Cell Biol; 2008 Oct; 28(20):6314-28. PubMed ID: 18694957
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.
Zhao Z; Ksiezak-Reding H; Riggio S; Haroutunian V; Pasinetti GM
Schizophr Res; 2006 May; 84(1):1-14. PubMed ID: 16581231
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of betatrophin enhances insulin sensitivity in type 2 diabetes mellitus through activation of the GSK-3β/PGC-1α signaling pathway.
Hao Q; Zheng A; Zhang H; Cao H
J Endocrinol Invest; 2021 Sep; 44(9):1857-1868. PubMed ID: 33464548
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.
Nair VD; Olanow CW
J Biol Chem; 2008 May; 283(22):15469-78. PubMed ID: 18387957
[TBL] [Abstract][Full Text] [Related]
10. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
12. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
13. Glutaredoxin 2 (GRX2) deficiency exacerbates high fat diet (HFD)-induced insulin resistance, inflammation and mitochondrial dysfunction in brain injury: A mechanism involving GSK-3β.
Wohua Z; Weiming X
Biomed Pharmacother; 2019 Oct; 118():108940. PubMed ID: 31382130
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
15. Effects of Agriophyllum squarrosum extracts on glucose metabolism in KKAy mice and the associated underlying mechanisms.
Saqier ; Bao S; Han S; Ao W
J Ethnopharmacol; 2019 Sep; 241():112009. PubMed ID: 31158442
[TBL] [Abstract][Full Text] [Related]
16. P27(Kip1), regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cells.
Wei M; Wang Z; Yao H; Yang Z; Zhang Q; Liu B; Yu Y; Su L; Zhu Z; Gu Q
BMC Cancer; 2011 Mar; 11():109. PubMed ID: 21439087
[TBL] [Abstract][Full Text] [Related]
17. GSK-3β function in bone regulates skeletal development, whole-body metabolism, and male life span.
Gillespie JR; Bush JR; Bell GI; Aubrey LA; Dupuis H; Ferron M; Kream B; DiMattia G; Patel S; Woodgett JR; Karsenty G; Hess DA; Beier F
Endocrinology; 2013 Oct; 154(10):3702-18. PubMed ID: 23904355
[TBL] [Abstract][Full Text] [Related]
18. Mice with beta cell overexpression of glycogen synthase kinase-3beta have reduced beta cell mass and proliferation.
Liu Z; Tanabe K; Bernal-Mizrachi E; Permutt MA
Diabetologia; 2008 Apr; 51(4):623-31. PubMed ID: 18219478
[TBL] [Abstract][Full Text] [Related]
19. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.
Singh LP; Jiang Y; Cheng DW
Int J Biol Sci; 2006 Oct; 3(1):27-39. PubMed ID: 17200689
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.
Bersudsky Y; Shaldubina A; Kozlovsky N; Woodgett JR; Agam G; Belmaker RH
Behav Pharmacol; 2008 May; 19(3):217-24. PubMed ID: 18469539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]